Everything exporters need to know about authenticating pharma and chemical trade documents for international buyers and regulators.
If you export APIs, bulk drugs, specialty chemicals, intermediates or formulations from India to international markets, there is a good chance your buyers or their national drug regulatory authorities will at some point ask for an apostilled document.
Unlike general trade, pharmaceutical and chemical exports involve a layer of regulatory oversight that extends far beyond the standard commercial invoice and shipping bill. Many destination countries - particularly in the Middle East, Africa, Southeast Asia, Latin America and regulated European markets - require that key documents originate from, and are verifiable by, a recognised government authority. The apostille is how Indian exporters satisfy that requirement internationally.
The demand for apostilled pharma documents has grown significantly as more countries tighten their product registration and import approval processes. Buyers submitting product dossiers to foreign drug regulatory agencies are increasingly required to include government-authenticated copies of the manufacturer's CoPP, GMP certificate and other documents. Without an apostille (or embassy attestation for non-Hague countries), these documents may not be accepted.
Not every document in a pharma export transaction requires apostille. The need arises specifically when a document is being submitted to a foreign authority - regulatory, governmental or institutional - that needs to verify its authenticity as an official Indian document. Here is a breakdown of the most commonly apostilled documents in pharmaceutical and chemical trade:
The CoPP is issued by the Central Drugs Standard Control Organisation (CDSCO) and certifies that a pharmaceutical product is manufactured and sold in India in conformity with Indian law. Many national drug regulatory agencies in Africa, the Middle East and Southeast Asia require an apostilled CoPP as part of the product registration or import licence application. Without apostille, the CoPP may be rejected as unverifiable. This is one of the most frequent apostille requests Sumsahi handles for pharma exporters.
The FSC confirms that a product is freely sold in India and has appropriate market approval. Like CoPP, it is commonly required for product registration in export markets. The FSC is typically issued by the CDSCO or a state drug authority, and its authentication follows the same PHD Chamber - MEA route as the CoPP.
Good Manufacturing Practice certificates are issued to manufacturing plants by state drug authorities or the CDSCO (for WHO-GMP). When submitted to foreign regulatory agencies as part of product registration, manufacturing partner approvals or tender documents, they may require apostille to confirm they are genuine government-issued documents.
For companies supporting USDMF or EU DMF filings, letters of authorisation and related official communications may need to be apostilled before submission to foreign regulators to confirm their authenticity and official origin.
State-issued manufacturing licences and letters authorising a distributor or agent to act on behalf of the manufacturer are commonly submitted to foreign buyers, regulatory authorities and government tender bodies. Apostille is often a condition for these documents to be accepted as legally valid in the destination country.
Power of Attorney, commercial contracts, agency agreements and company incorporation documents may require apostille when they are being submitted to foreign courts, government bodies, banks or commercial registries - particularly for setting up distribution arrangements or participating in regulated procurement.
For pharmaceutical and chemical trade documents, the standard authentication route in India is a two-step process before the apostille stamp is issued.
Commercial and trade documents - including Agreements, Power of Attorney, Commercial Contracts, and Manufacturing Licences - must first be attested by the PHD Chamber of Commerce & Industry (PHD) before being submitted to the MEA. The PHD Chamber is an authorised attestation body recognised by the MEA. Its stamp certifies that the signature on the document belongs to a legitimate signatory. Without PHD Chamber attestation, the MEA will not process commercial documents for apostille.
Note that CoPP and FSC documents issued by CDSCO or state drug authorities are treated as government documents and typically do not require PHD Chamber attestation - they go directly to MEA. However, the exact pre-attestation requirement depends on the issuing authority, and we recommend confirming this for each document type.
Following any required pre-attestation, documents are submitted to the Ministry of External Affairs in New Delhi for the apostille stamp. The MEA apostille is the final government certification required for Hague Convention countries. It is a red apostille sticker (or stamp for older format) affixed to the reverse of the document, confirming the document's official origin. MEA apostille typically takes 2-5 working days from submission.
If your destination country is not a member of the Hague Apostille Convention, the MEA-attested document must also be submitted to the relevant embassy or high commission in New Delhi for consular legalisation. This adds time to the process - anywhere from 3 working days to several weeks depending on the embassy. Common non-Hague destinations for Indian pharma exports include Saudi Arabia, Qatar, Kuwait, Pakistan, Bangladesh, Nepal and Malaysia.
For Hague countries: PHD Chamber (if needed) - MEA apostille
For non-Hague countries: PHD Chamber (if needed) - MEA attestation - Embassy legalisation
India joined the Hague Apostille Convention in 2005. This means that for all 124+ member countries, the MEA apostille is sufficient - no further embassy verification is required. For all other countries (non-Hague members), the older multi-step process applies.
For pharmaceutical exporters, the practical division looks like this:
Most of Western Europe (Germany, France, Italy, UK, Spain, Netherlands, and others), USA, Canada, Australia, Japan, South Korea, Singapore, South Africa, Mexico, Brazil, Turkey and most Latin American countries are Hague Convention members. The MEA apostille is legally accepted in all of these without any embassy involvement.
The following countries are commonly targeted by Indian pharma exporters but are NOT in the Hague Convention, meaning full embassy legalisation is required after MEA attestation: Saudi Arabia, Qatar, Kuwait, Oman, Bahrain (note: Bahrain joined Hague Convention in 2013 - always verify), Pakistan, Bangladesh, Nepal, Malaysia, Indonesia and others. The list changes as countries accede to the Convention - China, for example, acceded in 2023. Always confirm the current status for your specific destination before initiating the process.
Understanding realistic timelines is critical for planning your export documentation. Here is a practical breakdown:
A typical apostille for a Hague Convention country with PHD pre-attestation takes 4-7 working days from document receipt to delivery. For non-Hague countries with embassy attestation, allow at least 2-4 weeks and confirm the specific embassy timeline before committing to your buyer.
Apostille must be affixed to original documents. The MEA does not apostille photocopies or notarised copies for most document types. Always start the process with original government-issued documents. If you only have one original and need to protect it, discuss certified copy options with your agent before submitting.
Sending an apostilled document to a non-Hague country - or sending an embassy-attested document to a Hague country where a simple apostille would have sufficed - wastes time and money. Always confirm the destination country's current Hague Convention membership status before initiating the process.
Commercial documents submitted to MEA without PHD Chamber pre-attestation will be rejected. This is a frequent cause of delays for companies new to the apostille process. The PHD attestation is not optional for this document category - it is a mandatory intermediate step.
Apostille processing cannot be completed the same day. If your shipment or regulatory submission has a hard deadline, plan backwards from it: allow at least 2 weeks for standard Hague apostille including pre-attestation and delivery, and 4-6 weeks for non-Hague embassy attestation (more for some embassies). Last-minute requests may need express processing, which adds cost.
Most apostille agents in India specialise in personal documents (educational certificates, birth certificates). They may not know that a CoPP requires a different pre-attestation route than a commercial contract, or that some destination drug regulatory agencies have specific format requirements for the apostilled document. Working with an agent who understands the pharmaceutical trade avoids document rejections and back-and-forth delays.
If you need apostille or legalisation for pharmaceutical or chemical export documents, here is what to gather before reaching out to a service provider:
Sumsahi Kemicals offers a free initial document review - send us scanned copies of your documents with the destination country and purpose, and we'll come back with a process outline, required originals checklist and a fixed quote within one business day.
Sumsahi Kemicals specialises in apostille and legalisation for CoPP, FSC, GMP certificates and other pharma trade documents. Based in New Delhi - express service available.
Learn About Our Service Get a Free AssessmentSend us scanned copies and your destination country. Free review, fixed quote, express service available.